AI is transforming every industry – but healthcare may be where its impact is most profound.In this episode of CEO: Behind the Scenes, Naveen Jain, Founder and CEO of Viome Life Sciences, explains why advances in data collection, molecular biology and AI have finally converged to make personalized health possible at scale. He unpacks how AI can move healthcare from reactive treatment to proactive prevention – identifying disease years before symptoms appear.Jain outlines what it takes to turn overwhelming data into meaningful insight and why the future of medicine depends on understanding individuals, not averages. This conversation offers leaders a rare look at what’s coming next and what it means to manage health like a system, not a crisis.

Access our free digital content: https://digitalmag.theceomagazine.com

Follow us:  

LinkedIn: @the-ceo-magazine-global  

Facebook: @theceomagazineglobal  

X: @ceomagazinegl 

Instagram: @theceomagazineglobal  

Follow Naveen Jain and Viome Life Sciences:

LinkedIn: https://www.linkedin.com/in/naveenjainintelius/ 

Website: https://www.viomelifesciences.com/